Published in Kidney Int Suppl on February 01, 2001
Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol (2011) 1.44
T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage. Biomed Res Int (2015) 1.41
Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol (2011) 1.33
Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virchows Arch (2004) 1.06
Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol (2002) 1.04
Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol (2011) 0.93
Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis. Pediatr Nephrol (2007) 0.90
Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis. J Am Soc Nephrol (2015) 0.86
Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro. Int J Clin Exp Pathol (2015) 0.85
Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis. Adv Med (2014) 0.85
Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis. Am J Nephrol (2009) 0.84
Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease. Front Physiol (2015) 0.80
Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis. J Am Soc Nephrol (2016) 0.80
Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells. Pediatr Nephrol (2012) 0.79
A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis. J Am Soc Nephrol (2014) 0.79
Heme oxygenase-1 attenuates epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Clin Exp Nephrol (2012) 0.79
Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Kidney Res Clin Pract (2015) 0.78
Pharmacologic targets and peritoneal membrane remodeling. Perit Dial Int (2014) 0.76
Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence. Adv Perit Dial (2008) 0.75
Diabetes influences peritoneal morphology in uremic patients at the initiation of peritoneal dialysis. Perit Dial Int (2012) 0.75
Combined surgical and immunosupressive therapy for encapsulating peritoneal sclerosis. Indian J Nephrol (2016) 0.75
The impact of patient-centered care on outcomes. J Fam Pract (2000) 15.07
Randomization by cluster. Sample size requirements and analysis. Am J Epidemiol (1981) 9.21
WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet (2001) 6.86
Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80
Small sample performance of tests of homogeneity of odds ratios in K 2 x 2 tables. Stat Med (1992) 6.20
Evaluation of a palliative care service: problems and pitfalls. BMJ (1994) 5.70
Developments in cluster randomized trials and Statistics in Medicine. Stat Med (2007) 4.12
Approaches to sample size estimation in the design of clinical trials--a review. Stat Med (1984) 3.28
Sample size requirements for reliability studies. Stat Med (1987) 3.15
Analysis of data arising from a stratified design with the cluster as unit of randomization. Stat Med (1987) 3.01
Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79
Methods in health service research. Evaluation of health interventions at area and organisation level. BMJ (1999) 2.48
Peritoneal reaction to icodextrin in a female patient on CAPD. Perit Dial Int (2001) 2.38
The merits of matching in community intervention trials: a cautionary tale. Stat Med (1997) 2.14
The estimation of intraclass correlation in the analysis of family data. Biometrics (1980) 2.06
Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04
Adjustments to the Mantel-Haenszel chi-square statistic and odds ratio variance estimator when the data are clustered. Stat Med (1987) 2.00
Responsiveness of the short form-36, disability of the arm, shoulder, and hand questionnaire, patient-rated wrist evaluation, and physical impairment measurements in evaluating recovery after a distal radius fracture. J Hand Surg Am (2000) 1.98
Effects of candesartan and perindopril on renal function, TGF-beta1 plasma levels and excretion of prostaglandins in stable renal allograft recipients. Clin Nephrol (2002) 1.95
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Do family physicians need medical assistants to detect and manage hypertension? CMAJ (1986) 1.85
Current and future challenges in the design and analysis of cluster randomization trials. Stat Med (2001) 1.80
Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother (1977) 1.75
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71
Construction of confidence limits about effect measures: a general approach. Stat Med (2008) 1.69
Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59
Persistence of middle-ear effusion after acute otitis media in children. N Engl J Med (1979) 1.50
Clinical spectrum of gonococcal infection in women. Lancet (1977) 1.49
The "point of no return" and the rate of progression in the natural history of IgA nephritis. Clin Nephrol (1999) 1.49
Patient versus injury factors as predictors of pain and disability six months after a distal radius fracture. J Clin Epidemiol (2002) 1.46
Randomised study of n of 1 trials versus standard practice. BMJ (1996) 1.41
Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes. Kidney Int (1998) 1.40
Are ordinal models useful for classification? Stat Med (1991) 1.40
[Passive euthanasia in clinical practice--the medical decision reflected in the legal position]. Dtsch Med Wochenschr (2008) 1.39
Increasing sensitivity and specificity of Doppler sonographic detection of renal transplant rejection with serial investigation technique. Clin Investig (1994) 1.38
Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med (1997) 1.32
A regression approach to the analysis of data arising from cluster randomization. Int J Epidemiol (1985) 1.28
An empirical study of cluster randomization. Int J Epidemiol (1982) 1.26
Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Stat Med (2001) 1.26
Factors affecting the comparability of meta-analyses and largest trials results in perinatology. J Clin Epidemiol (1997) 1.24
Application of the McNemar test to non-independent matched pair data. Stat Med (1991) 1.22
Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin (1995) 1.21
Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl) (1988) 1.19
Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry (1993) 1.16
The design of controlled experiments in the evaluation of non-therapeutic interventions. J Chronic Dis (1982) 1.15
Effectiveness of the family physician in hypertension screening and management. Can Fam Physician (1982) 1.14
Sample size calculation for cluster randomized cross-over trials. Stat Med (2008) 1.13
A multivariate analysis of family data. Am J Epidemiol (1981) 1.11
SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex. Nucleic Acids Res (1999) 1.11
Randomization by cluster. Nurs Res (1991) 1.09
Trimethoprim-sulfamethoxazole compared with ampicillin in the treatment of acute otitis media. J Pediatr (1980) 1.09
Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy. Cell Death Differ (2003) 1.08
Orogenital contact and the isolation of Neisseria gonorrhoeae, Mycoplasma hominis, and Ureaplasma urealyticum from the pharynx. Sex Transm Dis (1979) 1.07
NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J Neurosci (2009) 1.06
Inference procedures for assessing interobserver agreement among multiple raters. Biometrics (2001) 1.04
The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q J Nucl Med Mol Imaging (2007) 1.04
Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest (1999) 1.04
Design considerations in the estimation of intraclass correlation. Ann Hum Genet (1982) 1.03
Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells. Exp Nephrol (2001) 1.03
Lipids and stroke: a paradox resolved. Arch Neurol (1996) 1.02
Basic helix-loop-helix protein sequences determining differential inhibition by calmodulin and S-100 proteins. J Biol Chem (1997) 1.02
Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH). Eur J Med Res (2011) 1.01
A comparison of confidence interval methods for the intraclass correlation coefficient. Biometrics (1986) 1.00
Oestrogen use and survival in endometrial cancer. Lancet (1980) 1.00
Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability. Cell Death Differ (2003) 1.00
Comparison between intraluminal multiple electric impedance measurement and manometry in the human oesophagus. Neurogastroenterol Motil (1996) 1.00
A novel type of calmodulin interaction in the inhibition of basic helix-loop-helix transcription factors. Biochemistry (2000) 0.99
Renal involvement in sarcoidosis--a report of 6 cases. Clin Nephrol (2002) 0.98
Eating out, weight and weight gain. A cross-sectional and prospective analysis in the context of the EPIC-PANACEA study. Int J Obes (Lond) (2010) 0.97
Application of the analysis of variance to hemagglutination titrations. J Immunol Methods (1973) 0.97
Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol (1997) 0.95
The WHO antenatal care randomised controlled trial: rationale and study design. Paediatr Perinat Epidemiol (1998) 0.95
Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant (2001) 0.94
Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant (2000) 0.94
Intravenous iloprost: a new therapeutic option for patients with post-transplant distal limb syndrome (PTDLS). Am J Transplant (2007) 0.93
Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat. Kidney Int (1999) 0.93
Long-term comparison of two surgical flap designs for third molar surgery on the health of the periodontal tissue of the second molar tooth. J Can Dent Assoc (1988) 0.93
Population pharmacodynamics of midazolam administered by target controlled infusion in SICU patients after CABG surgery. Anesthesiology (1998) 0.93
The effects of kaolin on the lung. Am Rev Respir Dis (1988) 0.92
Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol (2000) 0.92
The analysis of intraclass correlation in multiple samples. Ann Hum Genet (1985) 0.92
Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA. Mol Endocrinol (1999) 0.92
2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning. Med Toxicol Adverse Drug Exp (1987) 0.92
Case-control study of hair dye use by patients with breast cancer and endometrial cancer. J Natl Cancer Inst (1979) 0.92
Behavior pattern A and compliance with antihypertensive treatment. Acta Med Scand Suppl (1985) 0.92
Subthreshold oscillation of the membrane potential in magnocellular neurones of the rat supraoptic nucleus. J Physiol (2000) 0.92
Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol Nephrol (2001) 0.91
The use of correlation and regression in the analysis of family resemblance. Am J Epidemiol (1979) 0.91
Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg (2002) 0.91
Distal tubular acidosis induced by FK506. Clin Transplant (1998) 0.90
Value of flumazenil in benzodiazepine self-poisoning. Med Toxicol Adverse Drug Exp (1988) 0.90
Comparative value of the cold-pressor test and supine bicycle exercise to detect subjects with coronary artery disease using radionuclide ventriculography. Circulation (1982) 0.90
[Poisoning with Paraquat]. Dtsch Med Wochenschr (1971) 0.90
The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intensive Care Med (1999) 0.89
Indocyanine green video angiographies help to identify burns requiring operation. Burns (2003) 0.89
Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting. Anesthesiology (1998) 0.89
Angiographic progression of coronary artery disease in patients with end-stage renal disease. Nephrol Dial Transplant (2001) 0.89